As of 2026-09-22, the Relative Valuation of Constellation Pharmaceuticals Inc (CNST) is (61.71) USD. This relative valuation is based on P/E multiples. With the latest stock price at 33.99 USD, the upside of Constellation Pharmaceuticals Inc based on Relative Valuation is -281.6%.
The range of the Relative Valuation is (56.79) - (71.50) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.3x - 24.3x | 21.8x |
| Forward P/E multiples | 15.9x - 24.4x | 20.2x |
| Fair Price | (56.79) - (71.50) | (61.71) |
| Upside | -267.1% - -310.4% | -281.6% |
| Date | P/E |